Key Record Dates
ClinicalTrials.gov Identifier: | NCT05864924 |
---|---|
Brief Title: | A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma |
First Submitted : | April 27, 2023 |
First Submitted that Met QC Criteria : | May 16, 2023 |
First Posted : | May 18, 2023 |
Last Update Submitted that Met QC Criteria : | May 7, 2024 |
Last Update Posted : | May 8, 2024 |